Barclays Maintains Overweight on Braze, Raises Price Target to $38
Benzinga Newsdesk 2 months ago
NewsPrice TargetAnalyst Ratings
Barclays analyst Raimo Lenschow maintains Braze (NASDAQ:BRZE) with a Overweight and raises the price target from $31 to $38.
Barclays analyst Raimo Lenschow maintains Braze (NASDAQ:BRZE) with a Overweight and raises the price target from $31 to $38.